Pacific Biosciences of California Inc (PACB)
1.775
+0.06
(+3.20%)
USD |
NASDAQ |
May 10, 16:00
1.775
0.00 (0.00%)
After-Hours: 16:06
Pacific Biosciences of California Revenue (TTM): 200.52M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 200.52M |
| September 30, 2023 | 169.52M |
| June 30, 2023 | 146.14M |
| March 31, 2023 | 134.03M |
| December 31, 2022 | 128.30M |
| September 30, 2022 | 136.97M |
| June 30, 2022 | 139.55M |
| March 31, 2022 | 134.69M |
| December 31, 2021 | 130.51M |
| September 30, 2021 | 121.63M |
| June 30, 2021 | 105.82M |
| March 31, 2021 | 92.29M |
| December 31, 2020 | 78.89M |
| September 30, 2020 | 79.69M |
| June 30, 2020 | 82.52M |
| March 31, 2020 | 90.06M |
| December 31, 2019 | 90.89M |
| September 30, 2019 | 82.49M |
| June 30, 2019 | 78.73M |
| March 31, 2019 | 75.69M |
| December 31, 2018 | 78.63M |
| September 30, 2018 | 84.04M |
| June 30, 2018 | 89.42M |
| March 31, 2018 | 87.92M |
| December 31, 2017 | 93.47M |
| Date | Value |
|---|---|
| September 30, 2017 | 94.26M |
| June 30, 2017 | 95.83M |
| March 31, 2017 | 96.50M |
| December 31, 2016 | 90.71M |
| September 30, 2016 | 101.27M |
| June 30, 2016 | 90.07M |
| March 31, 2016 | 94.26M |
| December 31, 2015 | 92.78M |
| September 30, 2015 | 73.40M |
| June 30, 2015 | 80.11M |
| March 31, 2015 | 66.60M |
| December 31, 2014 | 60.59M |
| September 30, 2014 | 52.82M |
| June 30, 2014 | 39.62M |
| March 31, 2014 | 34.24M |
| December 31, 2013 | 28.18M |
| September 30, 2013 | 24.92M |
| June 30, 2013 | 20.28M |
| March 31, 2013 | 21.52M |
| December 31, 2012 | 25.98M |
| September 30, 2012 | 32.55M |
| June 30, 2012 | 40.29M |
| March 31, 2012 | 43.63M |
| December 31, 2011 | 33.86M |
| September 30, 2011 | 21.70M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
78.73M
Minimum
Jun 2019
200.52M
Maximum
Dec 2023
117.01M
Average
121.63M
Median
Sep 2021
Revenue (TTM) Benchmarks
| AtriCure Inc | 414.60M |
| BioSig Technologies Inc | -- |
| Intellia Therapeutics Inc | 36.28M |
| Shockwave Medical Inc | 787.97M |
| Outset Medical Inc | 130.38M |